Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pro-Pharmaceuticals requests pre-IND meeting with FDA to define regimen for EZ-646

July 16, 2008

Infinity discontinues enrollment in phase II IPI-504 study in prostate cancer

July 16, 2008

OSI initiates phase I OSI-027 in patients with advanced solid tumors or lymphoma

July 16, 2008

Motesanib diphosphate induces partial responses in patients with thyroid cancer

July 16, 2008

New anticancer agents described in recent patent literature

July 16, 2008

FDA accepts Genta's amendment to NDA for Genasense in CLL as complete response

July 15, 2008

FDA approves OncoGenex's SPA for phase III trial of OGX-011 in HRPC

July 15, 2008

Abraxis receives approval to market Abraxane for breast cancer in China

July 15, 2008

European Commission grants orphan designation to Marqibo for ALL

July 15, 2008

Recent patents disclose new compounds for treating cancer

July 15, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...